Gut check: could targeted vitamin B2 boost aging microbiomes?
NCT ID NCT07093463
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a colon-targeted form of vitamin B2 (riboflavin) can improve gut bacteria and digestive health better than regular vitamin B2 or a placebo. Researchers will enroll 90 healthy adults aged 50-70 to compare effects over 56 days. The goal is to understand how delivering vitamins directly to the gut may support a healthier microbiome.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GUT HEALTH are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
analyze & realize GmbH
RECRUITINGBerlin, State of Berlin, 10369, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily probiotic boost metabolic health and body confidence?
- Cow colostrum: a natural boost for gut, waistline, hair, and skin?
- Fiber and probiotics: a new hope for bloating and irregularity?
- Could a postbiotic soothe irritable bowel syndrome?
- Smartphone app aims to uncover food triggers for gut cancer survivors
- Lung germ shifts may predict pneumonia in brain surgery ICU patients